tiprankstipranks
Advertisement
Advertisement
Leerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal
PremiumThe FlyLeerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal
26d ago
Edwards jumps after CMS proposes to expand TAVR coverage
Premium
The Fly
Edwards jumps after CMS proposes to expand TAVR coverage
26d ago
TAVR NCD proposal ‘uber bullish’ for Edwards Lifesciences, says Evercore ISI
Premium
The Fly
TAVR NCD proposal ‘uber bullish’ for Edwards Lifesciences, says Evercore ISI
26d ago
Analyst Initiates Buy on Edwards Lifesciences, Citing Favorable TAVR Reimbursement Outlook and Expanded Patient Access Potential
PremiumRatingsAnalyst Initiates Buy on Edwards Lifesciences, Citing Favorable TAVR Reimbursement Outlook and Expanded Patient Access Potential
1M ago
Edwards Lifesciences price target raised to $104 from $97 at TD Cowen
Premium
The Fly
Edwards Lifesciences price target raised to $104 from $97 at TD Cowen
1M ago
Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan
Premium
Company Announcements
Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan
2M ago
Edwards Lifesciences price target raised to $110 from $104 at Barclays
PremiumThe FlyEdwards Lifesciences price target raised to $110 from $104 at Barclays
3M ago
Edwards Lifesciences price target raised to $90 from $89 at Truist
Premium
The Fly
Edwards Lifesciences price target raised to $90 from $89 at Truist
3M ago
Edwards Lifesciences price target raised to $93 from $92 at Evercore ISI
Premium
The Fly
Edwards Lifesciences price target raised to $93 from $92 at Evercore ISI
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100